JD HEALTH (06618) saw its stock soar by 5.08% in Tuesday's trading session, reflecting a broader rally in internet healthcare stocks. The surge comes as the National Medical Products Administration (NMPA) introduces new guidelines to regulate online prescription drug retail, potentially boosting investor confidence in the sector.

Other notable gainers in the internet healthcare space included DINGDANG HEALTH (09886), which surged 8.54%, and ALI HEALTH (00241), which climbed 6.16%. The NMPA's draft "Compliance Guidelines for Online Prescription Drug Retail" aims to enhance safety and regulatory compliance in online drug sales, addressing key areas such as quality control, information accuracy, and corporate responsibility.

Analysts at CITIC Securities view the healthcare industry positively, citing potential benefits from policy optimization, commercial insurance promotion, and AI empowerment. They anticipate improvements in revenue, profit, and cash flow across the sector, suggesting that both performance and valuations may experience a double boost from an annual perspective. This outlook, combined with the new regulatory framework, appears to be driving investor interest in internet healthcare stocks like JD HEALTH.